These programs provide medically tailored meals, groceries, and produce to support disease management, in combination with nutrition and culinary education, as part of a patients healthcare treatment plan
NICE-recommended pharmacological treatments currently include: Orlistat available on NHS prescription Semaglutide (Wegovy) approved by the MHRA for chronic weight management and subject to a phased NHS rollout, with eligibility criteria defined by NICE technology appraisal [21] [22] Tirzepatide (Zepbound) approved by the MHRA for chronic weight management
Schedule a Weight-Loss Consultation Interested in learning which option is right for you
The Precision Peptide Genetic Test can reveal genetic predispositions to GLP-1 sensitivity across 14 different metabolic pathways, helping personalize your treatment selection from the start
These effects are seen even outside of diabetes control.[ref] Related article: APOE genotype and Alzheimers risk Cardiovascular disease benefits: A number of studies have shown that GLP-1 RAs provide benefits for reducing cardiovascular disease
Several peptide systems were investigated before their receptors were cloned or before structurefunction relationships could be interrogated